JohnMoehrke SLS ValueSets Implementation Guide
0.1.0 - ci-build
JohnMoehrke SLS ValueSets Implementation Guide, published by John Moehrke. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/JohnMoehrke/SLSValueSets/ and changes regularly. See the Directory of published versions
| Official URL: http://johnmoehrke.github.io/SLSValueSets/ValueSet/ShiftMinSensitiveCodes | Version: 0.1.0 | |||
| Active as of 2026-09-16 | Computable Name: ShiftMinSensitiveCodes | |||
| Other Identifiers: OID:1.3.6.1.4.1.66281.18.48.28 | ||||
SHIFT SLS set of codes representing kinds of sensitive information requiring special privacy protections
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
This value set includes codes based on the following rules:
Expansion from tx.fhir.org based on:
This value set expansion contains 63 concepts.
| System | Code | Display (en) | Inactive | status | JSON | XML |
http://hl7.org/fhir/sid/icd-10-cm | F16.20 | Hallucinogen dependence, uncomplicated | ||||
http://snomed.info/sct | 724713006 | Harmful use of ketamine | inactive | inactive | ||
http://snomed.info/sct | 425741009 | Buprenorphine- and naloxone-containing product | ||||
http://snomed.info/sct | 5602001 | Harmful pattern of use of opioid | ||||
http://snomed.info/sct | 145121000119106 | Intravenous nondependent harmful pattern of use of opioid | ||||
http://snomed.info/sct | 1149222004 | Overdose | ||||
http://snomed.info/sct | 56876005 | Drug rehabilitation and detoxification | ||||
http://snomed.info/sct | 60112009 | Drug addiction counseling | ||||
http://snomed.info/sct | 61480009 | Drug detoxification | ||||
http://snomed.info/sct | 266707007 | Drug addiction therapy | ||||
http://snomed.info/sct | 52052004 | Rehabilitation therapy | ||||
http://snomed.info/sct | 6525002 | Dependent drug abuse | inactive | inactive | ||
http://www.nlm.nih.gov/research/umls/rxnorm | 352364 | buprenorphine / naloxone | ||||
http://www.nlm.nih.gov/research/umls/rxnorm | 1049221 | acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet | ||||
http://www.nlm.nih.gov/research/umls/rxnorm | 856987 | acetaminophen 300 MG / hydrocodone bitartrate 5 MG Oral Tablet | ||||
http://www.nlm.nih.gov/research/umls/rxnorm | 1860154 | Abuse-Deterrent 12 HR oxycodone hydrochloride 15 MG Extended Release Oral Tablet | ||||
http://hl7.org/fhir/sid/icd-10-cm | F11.11 | Opioid abuse, in remission | ||||
http://hl7.org/fhir/sid/icd-10-cm | F11.1 | Opioid abuse | ||||
http://snomed.info/sct | 720433000 | Patient Health Questionnaire Nine Item score | ||||
http://www.ama-assn.org/go/cpt | 96127 | Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | ||||
http://loinc.org | 44249-1 | PHQ-9 quick depression assessment panel [Reported.PHQ] | ||||
http://loinc.org | 89204-2 | Patient Health Questionnaire-9: Modified for Teens total score [Reported.PHQ.Teen] | ||||
http://www.nlm.nih.gov/research/umls/rxnorm | 315952 | fluoxetine 20 MG | ||||
http://snomed.info/sct | 372767007 | Fluoxetine | ||||
http://snomed.info/sct | 310496002 | Moderate depression | ||||
http://snomed.info/sct | 1376001 | Obsessive compulsive personality disorder | ||||
http://hl7.org/fhir/sid/icd-10-cm | F33.1 | Major depressive disorder, recurrent, moderate | ||||
http://hl7.org/fhir/sid/icd-10-cm | F60.5 | Obsessive-compulsive personality disorder | ||||
http://loinc.org | 76690-7 | Sexual orientation | ||||
http://snomed.info/sct | 42035005 | Bisexual | ||||
http://hl7.org/fhir/sid/icd-10-cm | N92.6 | Irregular menstruation, unspecified | ||||
http://snomed.info/sct | 80182007 | Irregular periods | ||||
http://hl7.org/fhir/sid/icd-10-cm | Z33.2 | Encounter for elective termination of pregnancy | ||||
http://snomed.info/sct | 18391007 | Elective termination of pregnancy | ||||
http://www.ama-assn.org/go/cpt | 59840 | Induced abortion, by dilation and curettage | ||||
http://www.cms.gov/Medicare/Coding/HCPCSReleaseCodeSets | S2260 | Induced abortion 17-24 weeks | ||||
http://www.nlm.nih.gov/research/umls/rxnorm | 1358781 | {21 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Oral Tablet) } Pack [Loestrin 1/20 21 Day] | ||||
http://www.nlm.nih.gov/research/umls/rxnorm | 1359031 | {21 (ethinyl estradiol 0.03 MG / norethindrone acetate 1.5 MG Oral Tablet) } Pack [Loestrin 1.5/30 21 Day] | ||||
http://www.nlm.nih.gov/research/umls/rxnorm | 330381 | mifepristone 200 MG | ||||
http://www.nlm.nih.gov/research/umls/rxnorm | 317128 | misoprostol 0.2 MG Oral Tablet | ||||
http://www.ama-assn.org/go/cpt | 76801 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, first trimester (< 14 weeks 0 days), transabdominal approach; single or first gestation | ||||
http://loinc.org | 48800-7 | Second trimester quad maternal screen panel - Serum or Plasma | ||||
http://loinc.org | 2106-3 | Choriogonadotropin [Presence] in Urine | ||||
http://loinc.org | 19080-1 | Choriogonadotropin [Units/volume] in Serum or Plasma | ||||
http://snomed.info/sct | 364324000 | Measure of pregnancy | ||||
http://snomed.info/sct | 440425000 | Number of births at term | ||||
http://snomed.info/sct | 440013005 | Number of preterm births | ||||
http://snomed.info/sct | 252113007 | Number of miscarriages or induced terminations of pregnancy | ||||
http://snomed.info/sct | 248991006 | Number of live deliveries | ||||
http://snomed.info/sct | 21840007 | Date of last menstrual period | ||||
http://hl7.org/fhir/sid/icd-10-cm | A56.2 | Chlamydial infection of genitourinary tract, unspecified | ||||
http://snomed.info/sct | 428015005 | Chlamydia trachomatis infection of genital structure | ||||
http://loinc.org | 92684-0 | Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis DNA panel - Urine by NAA with probe detection | ||||
http://www.nlm.nih.gov/research/umls/rxnorm | 330623 | azithromycin 500 MG | ||||
http://loinc.org | 80203-3 | HIV 1 and 2 Ab [Identifier] in Serum, Plasma or Blood by Rapid immunoassay | ||||
http://www.nlm.nih.gov/research/umls/rxnorm | 1747692 | Descovy | ||||
http://hl7.org/fhir/sid/icd-10-cm | T74.11 | Adult physical abuse, confirmed | ||||
http://hl7.org/fhir/sid/icd-10-cm | T74.11XA | Adult physical abuse, confirmed, initial encounter | ||||
http://hl7.org/fhir/sid/icd-10-cm | T74.11XS | Adult physical abuse, confirmed, sequela | ||||
http://snomed.info/sct | 706893006 | Victim of intimate partner abuse | ||||
http://hl7.org/fhir/sid/icd-10-cm | Z62.810 | Personal history of physical and sexual abuse in childhood | ||||
http://snomed.info/sct | 713834002 | Victim of child sexual exploitation | ||||
http://snomed.info/sct | 444175001 | Guided self-help cognitive behavioral therapy |
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |